| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTI-CENTER, GLOBAL STUDY OF VOLRUSTOMIG (MEDI5752) AS SEQUENTIAL THERAPY VERSUS OBSERVATION IN PARTICIPANTS WITH UNRESECTED LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA, WHO HAVE NOT PROGRESSED FOLLOWING DEFINITIVE CONCURRENT CHEMORADIOTHERAPY |
III |
in corso |
CANCRO TESTA-COLLO |
- SC Oncologia Clinica Sperimentale Testa – Collo |
|
A PHASE 2 AND PHASE 3 PERI-OPERATIVE TRIAL OF FIANLIMAB AND CEMIPLIMAB COMPARED WITH ANTI-PD1 ALONE IN PATIENTS WITH RESECTABLE STAGE III AND IV MELANOMA |
II/III |
in corso |
Melanoma |
- SC Oncologia Clinica Sperimentale del Melanoma – Immunoterapia e Terapie Innovative |
|
Studio di fase 2/3, randomizzato, in aperto su BT8009, in monoterapia o in combinazione, in partecipanti con carcinoma uroteliale localmente avanzato o metastatico (Duravelo-2) |
II/III |
in corso |
carcinoma uroteliale |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
APPROCCIO MULTIOMICO ALLA DIAGNOSI DELLE NEOPLASIE: THE ITALIAN NETWORK OF EXCELLENCE FOR ADVANCED DIAGNOSIS |
NA |
in corso |
NEOPLASIA |
SC Biologia Cellulare e Bioterapie - |
|
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma |
III |
in corso |
CARCINOMA TESTA-COLLO |
- SC Oncologia Clinica Sperimentale Testa – Collo |
